Program Book
Name
Disclosure Entity
Disclosure Type
Presentation Number
Schwarzenberger, Tobias
Nanion Technologies
Employment (full or part-time) in funding company 3702-Pos Employment (full or part-time) in funding company 2377-Pos Employment (full or part-time) in funding company 3070-Pos Employment (full or part-time) in funding company 3070-Pos Employment (full or part-time) in funding company 1033-Pos
Sellers, Scott
Gilead Sciences Schrodinger, Inc. Schrodinger, Inc.
Shelley, Mee Y. Shelley, John C. Shetty, Roshan Shorthouse, David Skinner, Joseph P.
Anasys Instruments Corp.
Lonza Biologics plc
Research funded by industry grant
318-Pos
Abbott
Employment (full or part-time) in funding company 996-Pos Employment (full or part-time) in funding company 90-Plat
Slack, Mark Solaro, Ross J.
Evotec AG
Cytokinetics, Inc.
Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson in company Stock options or bond holdings in a for-profit corporation or self-directed pension plan
2858-Pos
Song, Yonghong
MyoKardia, Inc.
2842-Pos
Song, Zhen
Gilead Sciences Inc., Foster City, California
Research funded by industry grant
3188-Plat
Song, Yonghong Sran, Arvinder
MyoKardia Inc MyoKardia, Inc.
Employment (full or part-time) in funding company 3692-Pos
Stock options or bond holdings in a for-profit corpo- ration or self-directed pension plan
2842-Pos
Sran, Arvinder S. Steindl, Juergen
MyoKardia Inc
Employment (full or part-time) in funding company 3692-Pos Employment (full or part-time) in funding company 680-Pos Employment (full or part-time) in funding company 680-Pos Employment (full or part-time) in funding company 680-Pos Employment (full or part-time) in funding company 3702-Pos Employment (full or part-time) in funding company 3702-Pos Employment (full or part-time) in funding company 694-Pos Consulting fees or other remuneration from industry 875-Pos Employment (full or part-time) in funding company 3861-Pos Employment (full or part-time) in funding company 3267-Plat Employment (full or part-time) in funding company 3687-Pos Employment (full or part-time) in funding company 996-Pos Employment (full or part-time) in funding company 3702-Pos Employment (full or part-time) in funding company 3097-Pos Employment (full or part-time) in funding company 1330-Pos Employment (full or part-time) in funding company 3292-Pos Employment (full or part-time) in funding company 736-Pos Ownership or Partnership in funding organization 2012-Pos Research funded by industry grant Research funded by industry grant 2684-Pos 2684-Pos Research funded by industry grant 2228-Plat
Nanion Technologies Nanion Technologies Nanion Technologies Nanion Technologies Nanion Technologies Nanion Technologies
Stengel, Timo
Stiehler, Johannes Stiehler, Johannes Stoelzle-Feix, Sonja Stoelzle-Feix, Sonja Stolarska, Magdalena
Corning, Inc. Firmenich Inc. Firmenich Inc.
Stone, Howard
Sun, Bo
Sunesen, Morten Sweitzer, Sharon M.
Sophion Bioscience GlaxoSmithKline Trim-edicine, Inc.
Tan, Tao
Tetin, Sergey Y. Thomas, Ulrich Thouin, Félix Tirunagari, Neeraj
Abbott
Nanion Technologies
Photon Etc.
Gilead Sciences Inc.
Tordo, Paul
Bruker
Tracka, Malgorzata B.
Medimmune Ltd.
Tranter, Pamela Trautman, Jay K. Trick, Jemma L. Uddin, Shahid Ullah, Aman Vaissière, Anaïs
Novartis
Aratome LLC
Oxford Nanopore Technologies
Research funded by industry grant
1067-Pos
Medimmune Ltd.
Employment (full or part-time) in funding company 3292-Pos
NVIDIA
Research funded by industry grant Research funded by industry grant
2179-Plat 2409-Pos
Servier
296
Biophysical Society 58 th Annual Meeting, San Francisco, California
Made with FlippingBook